Cost-Utility analysis of Insulin Degludec vs. Insulin Glargine U100 Treatment in Patients with Diabetes Mellitus type 1 and 2 in Serbia
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1885
https://www.valueinhealthjournal.com/article/S1098-3015(16)33251-X/fulltext
Title :
Cost-Utility analysis of Insulin Degludec vs. Insulin Glargine U100 Treatment in Patients with Diabetes Mellitus type 1 and 2 in Serbia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33251-X&doi=10.1016/j.jval.2016.09.1885
First page :
A674
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1780